Patents by Inventor Andrew John Collis

Andrew John Collis has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 10077458
    Abstract: A process for the microbial synthesis of migalastat, specifically a process for the production of migalastat comprising culturing a microorganism under conditions such that at least one imino sugar is produced and detecting and/or isolating an imino sugar produced by said microorganism, and the microorganisms used in this process. The invention also comprises migalastat produced according to the above method and pharmaceutical compositions and uses thereof.
    Type: Grant
    Filed: February 17, 2015
    Date of Patent: September 18, 2018
    Assignee: GlaxoSmithKline Intellectual Property Development Limited
    Inventors: Emilio Alvarez-Ruiz, Andrew John Collis, Alison Sarah Dann, Andrew Peter Fosberry, Sarah Jane Ready, Maria Jesus Vazquez Muniz
  • Publication number: 20180208955
    Abstract: A process for the microbial synthesis of migalastat, specifically a process for the production of migalastat comprising culturing a microorganism under conditions such that at least one imino sugar is produced and detecting and/or isolating an imino sugar produced by said microorganism, and the microorganisms used in this process. The invention also comprises migalastat produced according to the above method and pharmaceutical compositions and uses thereof.
    Type: Application
    Filed: March 8, 2018
    Publication date: July 26, 2018
    Inventors: Emilio ALVAREZ-RUIZ, Andrew John COLLIS, Alison Sarah DANN, Andrew Peter FOSBERRY, Sarah Jane READY, Maria Jesus VAZQUEZ MUNIZ
  • Publication number: 20160355856
    Abstract: A process for the microbial synthesis of migalastat, specifically a process for the production of migalastat comprising culturing a microorganism under conditions such that at least one imino sugar is produced and detecting and/or isolating an imino sugar produced by said microorganism, and the microorganisms used in this process. The invention also comprises migalastat produced according to the above method and pharmaceutical compositions and uses thereof.
    Type: Application
    Filed: February 17, 2015
    Publication date: December 8, 2016
    Inventors: Emilio ALVAREZ-RUIZ, Andrew John COLLIS, Alison Sarah DANN, Andrew Peter FOSBERRY, Sarah Jane READY, Maria Jesus VAZQUEZ MUNIZ
  • Patent number: 8263384
    Abstract: Novel organisms, including DNA construct host cell combinations, are disclosed. The organisms comprise a transcription unit (e.g. operon) comprising DNA sequences encoding for enzymes which promote the supply of single carbon units for the conversion of dUMP to dTMP. Examples include: dihydrofolate reductase genes e.g. T4 frd; Serine Hydroxymethyltransferase genes e.g. glyA; 3-phosphoglycerate dehydrogenase genes e.g. serA; and THF synthase genes e.g. ADE3. The organisms are used in a biological method of producing thymidine with significantly reduced levels of uridine.
    Type: Grant
    Filed: February 5, 2007
    Date of Patent: September 11, 2012
    Assignee: Glaxo Group Limited
    Inventors: David Martin Anderson, Andrew John Collis, Lin Liu, Sergey Podkovyrov, Christopher Preston
  • Publication number: 20090081735
    Abstract: Novel organisms, including DNA construct host cell combinations, are disclosed. The organisms comprise a transcription unit (e.g. operon) comprising DNA sequences encoding for enzymes which promote the supply of single carbon units for the conversion of dUMP to dTMP. Examples include: dihydrofolate reductase genes e.g. T4 frd; Serine Hydroxymethyltransferase genes e.g. glyA; 3-phosphoglycerate dehydrogenase genes e.g. serA; and THF synthase genes e.g. ADE3. The organisms are used in a biological method of producing thymidine with significantly reduced levels of uridine.
    Type: Application
    Filed: February 5, 2007
    Publication date: March 26, 2009
    Inventors: David Martin Anderson, Andrew John Collis, Lin Liu, Sergey Podkovyrov, Christopher Preston